OHSU in the news

A Step-by-Step Guide for Diagnosing Cushing Syndrome

Medscape August 23, 2024
In a Medscape step-by-step guide for diagnosing Cushing’s syndrome, Maria Fleseriu, M.D., says an early diagnosis is important: “It is likely that delayed diagnosis might explain the long-term consequences of Cushing’s syndrome, including increased morbidity and mortality despite remission.”

Beyond gene-edited babies: the possible paths for tinkering with human evolution

MIT Technology Review August 22, 2024
MIT Technology Review explores the future of gene editing, including the irresponsible use of the technology in 2018 by a researcher in China. Paula Amato, M.D., says, “He created this blowback, and brought to a halt many people’s research. And there were not many to begin with.” The story notes that OHSU is one of only two U.S. research institutions to publish research on gene editing in early human embryos.

New Covid Vaccines Are Coming. Here's What to Know.

The New York Times August 22, 2024
In a The New York Times article about when to get a COVID-19 shot and how long protection will last, Fikadu Tafesse, Ph.D., says people who are at high risk of developing severe disease should talk with a health care provider about the ideal interval between vaccines.

‘Symptom science’ research effort aims to optimize quality of life, minimize toxicities

HemOnc Today August 21, 2024
Eric Roeland, M.D., discusses the OHSU Knight Cancer Institute’s Symptom Science program, which is designed to mitigate toxicities and improve quality of life for people with cancer: “As we continue to develop highly effective drugs to treat cancer, we also need to prioritize that these treatments don’t have long-term side effects that limit the quality of life and independence of cancer survivors. It’s important that we co-develop strategies to minimize toxicities because patients are living with these effects, and they have equal importance in the development of drugs.”

‘Symptom science’ research effort aims to optimize quality of life, minimize toxicities

HemOnc Today August 21, 2024
Eric Roeland, M.D., discusses the OHSU Knight Cancer Institute’s Symptom Science program, which is designed to mitigate toxicities and improve quality of life for people with cancer: “As we continue to develop highly effective drugs to treat cancer, we also need to prioritize that these treatments don’t have long-term side effects that limit the quality of life and independence of cancer survivors. It’s important that we co-develop strategies to minimize toxicities because patients are living with these effects, and they have equal importance in the development of drugs.”

Traveling To Die: The Latest Form of Medical Tourism

Kaiser Health News August 20, 2024
Charles Blanke, M.D., contributes to a Kaiser Health News story on patients who travel out-of-state to receive Medical Aid in Dying care. He says that just because patients are willing to travel doesn’t mean it’s easy or that they get their desired outcome. "The law is pretty strict about what has to be done," he says.
See more stories